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Editorial on the Research Topic
Adaptive Immunity in Pregnancy
One of the most remarkable features of reproductive biology is the fact that a healthy woman can
successfully carry her genetically disparate conceptus to full term, without immune rejection.
The juxtaposition of the placenta and decidua creates what is referred to as the ‘fetal-maternal
interface’, where placental trophoblasts of fetal origin and maternal uterine lymphocytes come into
close contact. Due to the presence of paternal class I HLA-C molecules on trophoblasts, the
conceptus can be considered to resemble a semi-allograft. Conceptus-derived and placental-derived
antigens act to both prime maternal T cells and render the conceptus potentially susceptible to
inflammatory effector activity or T cell-mediated attack. After presentation of paternal alloantigens
by maternal antigen presenting cells (APCs), the maternal alloantigen-specific T cells proliferate and
secrete cytokines, responsible for the activation of allograft rejection or tolerance mechanisms,
respectively promoting pregnancy failure or fetal survival.
Therefore, the quality and strength of the adaptive immune response is critical to healthy
pregnancy. There is accumulating information that imbalance in the numbers, phenotypes and
functional activity of T cell subsets can adversely impact fertility and pregnancy health.
Predominant Th1, Th17 and Th17/Th1 immunity and decreased Th2, Th17/Th2 and Treg cells
are associated with recurrent pregnancy loss (RPL) of fetuses with normal fetal chromosomal
content. Various subsets of T cells are essential for pregnancy tolerance and interact in networks
with innate immune cells to counteract inflammation and promote robust placental development.
In fact, immune cells that populate the decidua are specialized not only to minimize events that
might evoke conceptus attack, but also to foster placental development and function and to combat
infections during pregnancy.
In addition, T cells are commonly perturbed in late gestation disorders including preeclampsia,
fetal growth restriction and spontaneous preterm birth. There is some evidence that T cell
disturbances precede the onset of symptoms and contribute to disease pathophysiology through
events around the time of implantation and early placental development.
In this Research Topic we welcomed six original articles and four review articles, which discuss the
role of novel immunosuppressive cells and molecules regulating fetal tolerance and development.
During pregnancy, sex steroid hormones like estrogen, progesterone, hCG but also a
progesterone-induced mediator, the progesterone-induced blocking factor (PIBF), which conveys
some of the immunological effects of progesterone, suppress effector immune activation resulting in
successful pregnancy. Csabai et al. reports that the implantation rate is decreased in mice treated
with anti-PIBF antibody. In these anti-PIBF-treated mice, NK activity, IL-12A mRNA expression inorg October 2021 | Volume 12 | Article 7702421
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expression of mRNA for IL-4 (a Th2-type cytokine) is decreased
in CD4+ T cells (Figure 1). Thus, PIBF plays an important role in
implantation by upregulating a Th2-type and downregulating
Th1-type immune responses.
As well as hormones, other molecules including the
prostaglandins (PG) can also regulate immune cells in pregnancy.
In particular Andrade et al. show that PGE2 also contributes to
immune tolerance, by inhibiting platelet aggregation and IL-5 and
IL-13productionby innate lymphoidcells (ILCs), andbysuppressing
neutrophil, NK cell and monocyte effector functions (Figure 1).
The role of Treg cells in pregnancy is extensively developed in
the Research Topic. Huang et al. reviewed the role of Treg in
normal pregnancy, in implantation failure, miscarriage,
endometriosis and preeclampsia. Krop et al. described not only
the role of well-known Foxp3+ Treg cells in pregnancy, and also
importantly the role of the lesser-known Foxp3- Treg cells, whichFrontiers in Immunology | www.frontiersin.org 2include HLA-G Treg cells, Tr1 cells that secrete IL-10 and
TGF-b, Th3 cells that secrete TGF-b, IL-10, and IL-4, CD8+
Treg cells, NO-Treg cells, TIGIT+ Treg cells, and Vd1+gdT cells
(Figure 1). However, the relationship between these Foxp3- Treg
cells and pregnancy disorders remains to be clarified.
Morita et al. examine CD8+ T cells that are less well studied in
pregnancy, in particular clonally expanded CD8+ T cells, using
single cell analysis of T cell receptor b (TCRb) sequences.
Clonally expanded CD8+ T cells may be a surrogate marker for
fetal/paternal antigen-specific CD8+ T cells. The authors show
that clonal CD8+ T cells are more abundant in effector memory
CD8+ T cells (CD8+EM) and that there are more CD8+ EM cells
in the decidua than in the peripheral blood. The clonal CD8+ T
cells increase from early to late pregnancy, and PD-1 expression,
which suppresses cytotoxic activity, is low on clonal CD8+ T cells
in early pregnancy but high in late pregnancy. The clonal PD1-
CD8+ T cells increase in miscarriages with normal fetalFIGURE 1 | Diagrammatic summary of critical elements of the adaptive immune response to pregnancy, that determine the balance between T cell tolerance and
T effector function, and influence the outcome of pregnancy and infant health. DC, dendritic cell; IDO, indoleamine-dioxygenase; MF, macrophage, PD1,
programmed death 1; PIBF, pregnancy-induced blocking factor; PMN-MDSC, polymorphonuclear myeloid-derived suppressor cell; PGE, prostaglandin E2; PGI,
prostaglandin I: Tr1, T regulatory 1; Th, T helper; TIGIT, T cell immunoglobulin and ITIM domain; Treg, regulatory T cell; uNK, uterine natural killer cell.October 2021 | Volume 12 | Article 770242
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not different in preeclampsia compared to normal pregnancy,
but PD-1 expression is significantly decreased, suggesting an
increased cytotoxic activity against fetal antigens in preeclampsia.
Immune cells can not only act by inducing trophoblast
tolerance but can also affect the structure of trophoblast by
altering the glycan chains of trophoblast. Dendritic cell activity
is particularly important, and may be amplified if NK cells are
removed as demonstrated by Borowski et al. Thus, immune cells
can influence the placental glycade and could impact placental
and fetal development (Figure 1). The relationship between the
alteration of trophoblast glycan chains and immune cells in
miscarriage and preeclampsia is an interesting topic for
future clarification.
Non-immune cells can also regulate immune cells responsible
for immune tolerance in pregnancy. Gori et al. showed that
endometrial decidualization increases tolerogenic dendritic cells
named DC-10 cells, which secrete IL-10 and induce different
regulatory T cells (Treg cells), including HLA-G+ Treg cells, Tr1
cells and Th3 cells (Figure 1).
Recently, polymorphonuclear myeloid-derived suppressor
cells (PMN-MDSCs) have been found to increase in the
pregnant uterus and play an important role in maintaining
pregnancy. Li et al. show that the number of decidual PMN-
MDSCs decrease in patients with unexplained recurrent
pregnancy loss. PMN-MDSC apoptosis, increased by elevated
TRAIL and decreased by DcR2, could explain the decreased
number of PMN-MDSCs in unexplained recurrent pregnancy
loss (Figure 1). The interaction between PMN-MDSCs and
immune cells such as Treg cells, need to be investigated.
Van der Zwan et al. usedmass cytometry to analyze lymphocyte
subpopulations in the decidua and peripheral blood. Such analysis
could be helpful for the classification of immunocompetent cells
and to clarify the role of each of these cells in the decidua. This
promising technology, whichmay serve as a foundation for further
identification of immune subsets in healthy and complicated
pregnancy, is set to offer further advances in the future.
Finally, it is important to recognize that the maternal adaptive
immune response to pregnancy has consequences not only for
pregnancy outcome, but also for the health of the child after
birth. Albrecht et al. review emerging studies showing that
cellular immunity is transferred from mother to child not onlyFrontiers in Immunology | www.frontiersin.org 3through IgG transfer during pregnancy, but also by maternal
cellular immunity transmitted to the child through lactation after
birth. This article introduces the interesting possibility of
transferring immunity to the fetus by vaccination during pregnancy.
In summary, this collection of papers provide a snapshot of the
state of this field and provide new insight on the mechanisms and
significance of the adaptive immune response to maternal and
infant health. Collectively the work highlights the imperative to
further delineate the underlying mechanisms by which maternal
tolerance is generated andmediated, so that interventions toprotect
against immune-based pregnancy disorders arising from
compromise maternal tolerance can be advanced.AUTHOR CONTRIBUTIONS
All authors listed have made a substantial, direct, and
intellectual contribution to the work and approved it
for publication.ACKNOWLEDGMENTS
We thank the authors of the 10 publications of the Research
Topic for their high-quality work. We thank the Frontiers in
Immunology Editorial Office and the Editor for their support.
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Publisher’s Note: All claims expressed in this article are solely those of the authors
and do not necessarily represent those of their affiliated organizations, or those of
the publisher, the editors and the reviewers. Any product that may be evaluated in
this article, or claim that may be made by its manufacturer, is not guaranteed or
endorsed by the publisher.
Copyright © 2021 Piccinni, Robertson and Saito. This is an open-access article
distributed under the terms of the Creative Commons Attribution License
(CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) and the copyright owner(s) are credited and that
the original publication in this journal is cited, in accordance with accepted
academic practice. No use, distribution or reproduction is permitted which does
not comply with these terms.October 2021 | Volume 12 | Article 770242
